180:@0.085057:0.957873:0.109689:0.957873:0.109689:0.938882:0.085057:0.938882:0.007450:0.008591:0.008591
7:@0.038824:0.559752:0.060302:0.559752:0.060302:0.512274:0.038824:0.512274:0.021478
CHAPTER 7:@0.117647:0.067123:0.189199:0.067123:0.189199:0.047044:0.117647:0.047044:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.007097
these resources need to be public and fully open access for the benefit of technologi-:@0.117647:0.121273:0.852941:0.121273:0.852941:0.100900:0.117647:0.100900:0.006620:0.011299:0.009039:0.007875:0.009039:0.006460:0.007442:0.009039:0.007875:0.010820:0.011413:0.007442:0.008994:0.009039:0.007670:0.006460:0.011596:0.009108:0.009108:0.011391:0.006460:0.006209:0.011048:0.006460:0.011254:0.009039:0.006460:0.011048:0.011345:0.010911:0.005250:0.005547:0.008994:0.006460:0.009085:0.011596:0.011391:0.006460:0.006369:0.011550:0.005387:0.005182:0.009724:0.006460:0.010820:0.011502:0.009039:0.011756:0.006460:0.009291:0.008994:0.008994:0.009039:0.007533:0.007670:0.006460:0.006026:0.010843:0.007807:0.006460:0.006620:0.011299:0.009039:0.006460:0.011254:0.009039:0.011596:0.009039:0.005684:0.005341:0.006437:0.006460:0.010843:0.006209:0.006460:0.006209:0.009106:0.008768:0.011459:0.011598:0.010934:0.005182:0.011048:0.009861:0.005704:0.007533
cal advance. Also, other groups have developed computational enrichment approaches :@0.117647:0.141852:0.857029:0.141852:0.857029:0.121479:0.117647:0.121479:0.009108:0.009405:0.005250:0.005250:0.009291:0.011322:0.009838:0.009085:0.011596:0.008994:0.008743:0.004497:0.005250:0.015066:0.005250:0.007875:0.010272:0.004497:0.005250:0.010820:0.006620:0.011299:0.009039:0.007807:0.005250:0.009861:0.007442:0.010820:0.011071:0.011185:0.007670:0.005250:0.011391:0.008925:0.009633:0.009039:0.005250:0.011322:0.009336:0.009633:0.008948:0.005182:0.010820:0.011505:0.009108:0.011391:0.005250:0.008994:0.010843:0.017280:0.011048:0.011071:0.006551:0.008811:0.006437:0.005545:0.010845:0.011687:0.009405:0.005250:0.005250:0.009039:0.011756:0.007807:0.005545:0.008768:0.011459:0.017488:0.009039:0.011391:0.006437:0.005250:0.008811:0.011048:0.011071:0.007442:0.011137:0.009291:0.008765:0.011299:0.009039:0.007670:0.004109
with nanopore sequencing. Rather than using wet-lab Cas9-based enrichment, specific :@0.117647:0.162431:0.857109:0.162431:0.857109:0.142058:0.117647:0.142058:0.014723:0.005273:0.006620:0.011459:0.004988:0.011690:0.009085:0.011596:0.010820:0.011502:0.010845:0.007442:0.009039:0.004988:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009679:0.004497:0.004999:0.013902:0.008811:0.006617:0.011302:0.009039:0.007807:0.004988:0.006620:0.011391:0.009085:0.011756:0.004999:0.011413:0.007601:0.005615:0.011459:0.009861:0.004999:0.014518:0.009131:0.006437:0.007533:0.005430:0.009108:0.011025:0.004999:0.014974:0.009291:0.007670:0.010432:0.007533:0.011114:0.009291:0.007875:0.009108:0.011391:0.004999:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017488:0.009039:0.011391:0.006437:0.004497:0.004999:0.007510:0.011505:0.009108:0.008994:0.005615:0.005684:0.005615:0.008994:0.004109
targeted regions are sequenced by mapping the read in real-time while it traverses the :@0.117647:0.183009:0.857050:0.183009:0.857050:0.162636:0.117647:0.162636:0.006551:0.009085:0.007624:0.009656:0.009131:0.006209:0.009108:0.011391:0.005807:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.005809:0.009085:0.007442:0.009039:0.005809:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009108:0.011391:0.005807:0.010843:0.009724:0.005809:0.017577:0.008811:0.011048:0.011071:0.005615:0.011459:0.009861:0.005809:0.006620:0.011299:0.009039:0.005807:0.007442:0.009291:0.009291:0.011391:0.005809:0.005615:0.011756:0.005807:0.007444:0.009288:0.009405:0.005250:0.007533:0.006437:0.005615:0.017485:0.009039:0.005809:0.014789:0.011459:0.005752:0.005182:0.009039:0.005809:0.005273:0.006437:0.005809:0.006437:0.007896:0.008928:0.009633:0.009039:0.007624:0.007873:0.009039:0.007670:0.005809:0.006620:0.011299:0.009039:0.004109
pore and rejecting it when it is not part of the target region:@0.117647:0.203588:0.627253:0.203588:0.627253:0.183215:0.117647:0.183215:0.011505:0.010843:0.007442:0.009039:0.005912:0.009085:0.011596:0.011391:0.005912:0.007442:0.009131:0.005341:0.009106:0.009108:0.006437:0.005615:0.011459:0.009861:0.005912:0.005273:0.006437:0.005912:0.014792:0.011299:0.009039:0.011756:0.005901:0.005273:0.006437:0.005912:0.005615:0.007670:0.005912:0.011596:0.010820:0.006437:0.005912:0.011368:0.009085:0.007967:0.006437:0.005912:0.010843:0.006209:0.005901:0.006620:0.011299:0.009039:0.005912:0.006551:0.009085:0.007624:0.009656:0.009131:0.006437:0.005912:0.007442:0.009039:0.009861:0.005547:0.010843:0.011756
429,430:@0.627160:0.195972:0.666272:0.195972:0.666272:0.184095:0.627160:0.184095:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
. This dry enrichment :@0.666271:0.203588:0.857068:0.203588:0.857068:0.183215:0.666271:0.183215:0.004497:0.005912:0.011470:0.011470:0.005615:0.007670:0.005901:0.011391:0.008400:0.009724:0.005912:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.004109
technique was used by Miller :@0.117647:0.224167:0.374149:0.224167:0.374149:0.203794:0.117647:0.203794:0.006209:0.009108:0.008765:0.011459:0.011756:0.005547:0.010706:0.011345:0.009039:0.005958:0.014723:0.009291:0.007670:0.005958:0.011413:0.007875:0.009108:0.011391:0.005958:0.010840:0.009724:0.005958:0.019426:0.005752:0.005387:0.005182:0.009039:0.007807:0.004109
et al.:@0.375990:0.224167:0.416531:0.224167:0.416531:0.203584:0.375990:0.203584:0.008081:0.006300:0.006095:0.009952:0.005068:0.005045
431:@0.416523:0.216551:0.434769:0.216551:0.434769:0.204673:0.416523:0.204673:0.006082:0.006082:0.006082
 to enrich suspected regions and discover patho-:@0.434768:0.224167:0.852941:0.224167:0.852941:0.203794:0.434768:0.203794:0.005958:0.006209:0.011048:0.005958:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.005958:0.007510:0.011413:0.007510:0.011505:0.009108:0.009108:0.006209:0.009108:0.011391:0.005958:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.005958:0.009085:0.011596:0.011391:0.005958:0.011391:0.005615:0.007873:0.008994:0.010866:0.009633:0.009039:0.007807:0.005958:0.011365:0.008813:0.006620:0.011299:0.011037:0.007533
genic SVs in Mendelian disorders. By combining these computational enrichment with :@0.117647:0.244745:0.857027:0.244745:0.857027:0.224373:0.117647:0.224373:0.009656:0.009039:0.011756:0.005547:0.008994:0.004588:0.010112:0.015089:0.007670:0.004588:0.005615:0.011756:0.004588:0.018969:0.009039:0.011596:0.011322:0.008948:0.005250:0.005798:0.009085:0.011756:0.004588:0.011391:0.005615:0.007875:0.010843:0.007442:0.011322:0.009039:0.007624:0.007670:0.004497:0.004588:0.012555:0.009724:0.004588:0.008994:0.010843:0.017394:0.010820:0.005615:0.011756:0.005615:0.011459:0.009861:0.004588:0.006620:0.011299:0.009039:0.007873:0.009039:0.004588:0.008994:0.010843:0.017282:0.011048:0.011069:0.006551:0.008811:0.006437:0.005547:0.010843:0.011690:0.009402:0.005250:0.004588:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.004588:0.014723:0.005273:0.006620:0.011459:0.004109
our approaches, perhaps more target regions and higher enrichments in cancer-relevant :@0.117647:0.265324:0.857050:0.265324:0.857050:0.244951:0.117647:0.244951:0.010820:0.011413:0.007807:0.004143:0.008811:0.011048:0.011071:0.007442:0.011139:0.009291:0.008765:0.011299:0.009039:0.007670:0.004497:0.004143:0.011505:0.009039:0.007601:0.011391:0.008811:0.011185:0.007670:0.004141:0.017488:0.010843:0.007442:0.009039:0.004143:0.006549:0.009087:0.007624:0.009656:0.009131:0.006437:0.004143:0.007442:0.009039:0.009861:0.005547:0.010840:0.011621:0.007670:0.004143:0.009085:0.011596:0.011391:0.004143:0.011459:0.005615:0.009927:0.011299:0.009039:0.007807:0.004143:0.009039:0.011756:0.007807:0.005547:0.008765:0.011459:0.017485:0.009039:0.011391:0.006437:0.007670:0.004143:0.005615:0.011756:0.004143:0.009108:0.009085:0.011596:0.008994:0.009039:0.007236:0.007533:0.007442:0.008948:0.005182:0.009336:0.009838:0.009085:0.011391:0.006437:0.004109
regions could be achieved, increasing confidence in the biomarkers that we detect and :@0.117647:0.285903:0.857027:0.285903:0.857027:0.265530:0.117647:0.265530:0.007442:0.009039:0.009861:0.005547:0.010843:0.011619:0.007670:0.005501:0.008994:0.010820:0.011550:0.005182:0.011391:0.005501:0.011254:0.009039:0.005501:0.009291:0.008765:0.011459:0.005547:0.009336:0.009633:0.009108:0.011117:0.004497:0.005501:0.005615:0.011596:0.008994:0.007442:0.009291:0.009291:0.007601:0.005615:0.011459:0.009861:0.005501:0.008994:0.010843:0.011756:0.005684:0.005615:0.011322:0.009039:0.011596:0.008994:0.009039:0.005501:0.005615:0.011756:0.005501:0.006620:0.011299:0.009039:0.005501:0.010820:0.005547:0.010843:0.017577:0.009085:0.007601:0.010272:0.009039:0.007624:0.007670:0.005501:0.006620:0.011391:0.008811:0.006437:0.005501:0.014518:0.009039:0.005501:0.011322:0.009131:0.006209:0.009106:0.009108:0.006437:0.005501:0.009085:0.011596:0.011391:0.004109
reducing post-analysis validation. :@0.117647:0.306482:0.404258:0.306482:0.404258:0.286109:0.117647:0.286109:0.007442:0.009108:0.011048:0.011345:0.008994:0.005615:0.011459:0.009861:0.004109:0.011505:0.010955:0.007512:0.006437:0.007533:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004109:0.009838:0.009402:0.005250:0.005547:0.011573:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109